Priothera Ltd.
3 known investors
Priothera is a clinical-stage biopharmaceutical company developing mocravimod, an investigational immune modulator intended as a maintenance therapy for allogeneic hematopoietic cell transplantation. Its work targets hematological malignancies such as acute myeloid leukemia, aiming to enhance the graft-versus-leukemia effect while reducing graft-versus-host disease.
Founders & leadership
FG
Florent GrosFounder & CEO
Investors · 3
In the news
Frequently asked questions
- What does Priothera Ltd. do?
- Priothera is a clinical-stage biopharmaceutical company developing mocravimod, an investigational immune modulator intended as a maintenance therapy for allogeneic hematopoietic cell transplantation. Its work targets hematological malignancies such as acute myeloid leukemia, aiming to enhance the graft-versus-leukemia effect while reducing graft-versus-host disease.
- Who founded Priothera Ltd.?
- Priothera Ltd. was founded by Florent Gros.
- Who are Priothera Ltd.'s investors?
- Priothera Ltd.'s investors include 4see Ventures, Fountain Healthcare Partners, HealthCap.